RxDoctor Payments Data

Bianca Caram

Obstetrics & Gynecology · Dallas, TXNPI 1275891632

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,600 of the $5,147 with a category attached, or 69.9%. Mimedx Group, Inc. accounts for 69.9% of it on its own, with 25 other manufacturers making up the rest. 2025 is the largest year on record at $2,965, more than ten times the $146 reported in 2019.

$5,147in general payments, 2019–2025

Across 81 payments — averaging $63.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mimedx Group, Inc.$4K
  • Sumitomo Pharma America, Inc.$241
  • AbbVie$206
  • Organon$199
  • Exeltis, USA Inc.$156
  • Shield Therapeutics Inc$154
  • plus $591 from 20 others

What the payments were for

  • Consulting fees$3,60070%
  • Food & beverage$1,52130%
  • Education$261%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,147 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol17$166

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →